These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 84092)

  • 21. Tumor-associated antigen of spontaneous mammary tumor in rats.
    Imamura N; Yanagihara K; Kusunoki Y
    Oncology; 1984; 41(3):206-9. PubMed ID: 6427720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of tumor cells from a single mouse mammary tumor.
    Dexter DL; Kowalski HM; Blazar BA; Fligiel Z; Vogel R; Heppner GH
    Cancer Res; 1978 Oct; 38(10):3174-81. PubMed ID: 210930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro differentiation and progression of mouse mammary tumor cells.
    Sonnenberg A; Daams H; Calafat J; Hilgers J
    Cancer Res; 1986 Nov; 46(11):5913-22. PubMed ID: 3756929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ Fc receptor-bearing cells in two murine tumors. II. Role in tumor immunity.
    Korn JH; Haskill JS; Holden HT; Radov LA; Ritter FL
    J Natl Cancer Inst; 1978 Jun; 60(6):1391-7. PubMed ID: 306442
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
    Rios A; Simmons RL
    Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serologically detectable specific and cross-reactive antigens on the membrane of a polyoma virus-induced murine tumor.
    Witz IP; Lee N; Klein G
    Int J Cancer; 1976 Aug; 18(2):243-9. PubMed ID: 60289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytotoxic antibodies in the serum of C3H mice after inoculating them with spontaneous mammary gland tumor cells].
    Lavrovskiĭ VA; Viksler VKh
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):57-61. PubMed ID: 227196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
    Marconi P; Bistoni F; Pitzurra M
    Boll Soc Ital Biol Sper; 1973 May; 49(10):534-8. PubMed ID: 4132962
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative assay for tumor antigen based on inhibition of cytotoxicity of sensitized lymphocytes.
    Huber S; Lucas ZJ
    Int J Cancer; 1979 Feb; 23(2):224-32. PubMed ID: 83968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural antibody in mammary tumor virus-infected mice that reacts with intracytoplasmic A particles of mouse mammary tumors.
    Zotter S; Müller M
    J Natl Cancer Inst; 1977 Apr; 58(4):967-75. PubMed ID: 191630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour.
    Comoglio PM; Bertini M; Forni G
    Immunology; 1975 Aug; 29(2):353-64. PubMed ID: 51002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of small doses of the tumor specific antigen on further tumor growth].
    Rejthar A; Wotke J
    Cesk Patol; 1974 Nov; 10(4):188-91. PubMed ID: 4142601
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of monoclonal antibodies against MM antigen: the serologic identification of MM antigen with Ly-6.2 alloantigen.
    Seto M; Takahashi T; Tanimoto M; Nishizuka Y
    J Immunol; 1982 Jan; 128(1):201-5. PubMed ID: 6976371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
    Gillette RW; Wunderlich DA
    Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-induced antigen redistribution on murine mammary tumor cells.
    Kurisu M; Dohi N; Yamazaki M; Mizuno D
    Gan; 1980 Aug; 71(4):530-5. PubMed ID: 7191814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sera from irradiated rats contain antibodies to a ubiquitous tumour-associated antigen.
    Bentvelzen P; Dubbeld MA; Koornstra WH; Broerse JJ; Van Zwieten MJ
    Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1255-63. PubMed ID: 6311562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.